Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL6060061 | 0.90 | ALDH1A1 (0.35) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| SCHEMBL196996 | 0.87 | CES1 (0.41) | ALDH1A1CES2CES1TSHR | |
| SCHEMBL10878315 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| Acetic Acid SCHEMBL27985605 | 0.82 | TSHR (0.38) | ALDH1A1CES2CES1TSHR | |
| SCHEMBL1298570 | 0.81 | — | — | |
| SCHEMBL61201 | 0.81 | — | — | |
| SCHEMBL197960 | 0.81 | — | — | |
| Propionic Acid SCHEMBL27983610 | 0.81 | AKR1B1 (0.38) | ALDH1A1CES2CES1FFAR3TSHR | |
| SCHEMBL6283558 | 0.80 | ALDH1A1 (0.36) | ALDH1A1CES2CES1HDAC3HDAC1 | |
| SCHEMBL8641857 | 0.80 | TSHR (0.42) | ALDH1A1CES2CES1HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903379-A | High-wear-resistance resin for marble and preparation method thereof | 顾家家居股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20230263938-A1 | Dental Coating Composition and Method of Use | MYCONE DENTAL SUPPLY CO INC (US) | 2023-08-24 | — | — | US | disclosed |
| CN-114656589-B | Underwater direct operation type high-strength wet adhesive material and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2022-11-11 | — | — | CN | disclosed |
| CN-114656589-A | Underwater direct operation type high-strength wet adhesive material and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2022-06-24 | — | — | CN | disclosed |
| US-20200315945-A1 | Actinic Light Curable Dip System | MYCONE DENTAL SUPPLY CO., INC. (US) | 2020-10-08 | — | — | US | disclosed |
| CN-109943264-B | High-strength wet-adhesion bionic adhesive material and method and application thereof | 中国科学院兰州化学物理研究所 | 2020-02-07 | — | — | CN | disclosed |
| US-20190151223-A1 | ONE PART ARTIFICIAL NAIL COMPOSITIONS | MYCONE DENTAL SUPPLY CO INC (US) | 2019-05-23 | — | — | US | disclosed |
| US-20190151222-A1 | ONE PART ARTIFICIAL NAIL SCULPTING COMPOSITIONS AND METHODS WITHOUT REACTIVE OLIGOMERS | NAIL ALLIANCE, LLC | 2019-05-23 | — | — | US | disclosed |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | MYCONE DENTAL SUPPLY CO INC (US) | 2019-05-02 | — | — | US | disclosed |
| EP-3471831-A1 | ONE PART ACRYLIC NAIL FORMULATION | Mycone Dental Supply Company, Inc. (US) | 2019-04-24 | — | — | EP | disclosed |
| US-20150343192-A1 | LIQUID MEDICINE INJECTION DEVICE OF SUBCUTANEOUS IMPLANT TYPE | TERUMO CLINICAL SUPPLY CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
| WO-2015031418-A1 | MICROCAPSULE-CONTAINING DETERGENT OR CLEANING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-2796163-A1 | SUBCUTANEOUSLY IMPLANTED DEVICE FOR INJECTING DRUG SOLUTION | Terumo Clinical Supply Co., Ltd. (JP) | 2014-10-29 | — | — | EP | disclosed |
| US-20100178315-A1 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | VISTA SCIENTIFIC LLC (US) | 2010-07-15 | — | — | US | disclosed |
| US-20060198892-A1 | Polymeric systems for controlled drug therapy | AMORPHEX THERAPEUTICS LLC | 2006-09-07 | — | — | US | disclosed |
| EP-0263353-A2 | Copolymers of alpha-cyanoacrylates and acrylates, their preparation and use | BAYER AG (DE) | 1988-04-13 | — | — | EP | disclosed |
| US-4423193-A | WITH ANTIAGGLOMERANT CONSISTING OF WATER SOLUBLE ELECTROLYTE SOLID AND WEAK BASE | THE GENERAL TIRE & RUBBER COMPANY (US) | 1983-12-27 | — | — | US | disclosed |
| US-4409343-A | DIENE AND VINYLPHYRIDINE COPOLYMERS | THE GENERAL TIRE & RUBBER COMPANY (US) | 1983-10-11 | — | — | US | disclosed |
| US-4409290-A | HEAT CURABLE ADHESIVE WHICH IS BLEND OF GRAFT COPOLYMER OF ACRYLIC MONOMER, AND VINYL PYRIDINE MONOMER WITH PHENOLIC RESIN | THE GENERAL TIRE & RUBBER COMPANY (US) | 1983-10-11 | — | — | US | disclosed |
| US-4355131-A | Adhesion of rubber to glass fibers | THE GENERAL TIRE & RUBBER COMPANY (US) | 1982-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151223-A1 | ONE PART ARTIFICIAL NAIL COMPOSITIONS | POLR1C, PIK3C3, NACA | ALDH1A1 3782/4885CES2 2933/4885CES1 4562/4885 |
| US-20190151222-A1 | ONE PART ARTIFICIAL NAIL SCULPTING COMPOSITIONS AND METHODS WITHOUT REACTIVE OLIGOMERS | POLR1C, NACA, SUCLG1 | ALDH1A1 2608/4885CES2 4615/4885CES1 4875/4885 |
| US-20060198892-A1 | Polymeric systems for controlled drug therapy | PAICS, ABCB1, CES2 | ALDH1A1 1993/4885CES2 3/4885CES1 181/4885 |
| US-20200315945-A1 | Actinic Light Curable Dip System | POLR1C, ACTL6A, ACTN1 | ALDH1A1 975/4885CES2 3432/4885CES1 4697/4885 |
| US-20100178315-A1 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | PAICS, ABCB1, CES2 | ALDH1A1 1993/4885CES2 3/4885CES1 181/4885 |
| US-20230263938-A1 | Dental Coating Composition and Method of Use | TAS2R42, TAS2R41, TAS2R40 | ALDH1A1 2880/4885CES2 718/4885CES1 4244/4885 |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | POLR1C, NACA, PIK3C3 | ALDH1A1 321/4885CES2 3274/4885CES1 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.